BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi B, Zhang X, Chao L, Zheng Y, Tan Y, Wang L, Zhang W. Comprehensive analysis of key genes, microRNAs and long non-coding RNAs in hepatocellular carcinoma. FEBS Open Bio 2018;8:1424-36. [PMID: 30186744 DOI: 10.1002/2211-5463.12483] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Huang X, Zhu S, Zhang K, Tan W, Chen Y, Shang C. High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma. Front Mol Biosci 2022;9:814058. [DOI: 10.3389/fmolb.2022.814058] [Reference Citation Analysis]
2 Zhao ZB, Chen F, Bai XF. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a. Yonsei Med J 2019;60:727-34. [PMID: 31347327 DOI: 10.3349/ymj.2019.60.8.727] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
3 Wang Y, Cai X. Long noncoding RNA HAND2-AS1 restrains proliferation and metastasis of breast cancer cells through sponging miR-1275 and promoting SOX7. CBM 2019;27:85-94. [DOI: 10.3233/cbm-190530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Xu G, Xu WY, Xiao Y, Jin B, Du SD, Mao YL, Zhang ZT. The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma. Cancer Cell Int 2020;20:496. [PMID: 33061848 DOI: 10.1186/s12935-020-01581-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zheng J, Wu D, Wang L, Qu F, Cheng D, Liu X. mir-182-5p Regulates Cell Growth of Liver Cancer via Targeting RCAN1. Gastroenterol Res Pract 2021;2021:6691305. [PMID: 33959160 DOI: 10.1155/2021/6691305] [Reference Citation Analysis]
6 Hu WY, Wei HY, Liu LY, Li KM, Wang RB, Xu XQ, Feng R. miR-3607, a biomarker of hepatocellular carcinoma invasion and aggressiveness: Its relationship with epithelial-mesenchymal transition process. IUBMB Life 2020;72:1686-97. [PMID: 32311821 DOI: 10.1002/iub.2291] [Reference Citation Analysis]
7 Wang H, Wang B, Wang T, Fan R. A genetic variant in the promoter region of miR-877 is associated with an increased risk of hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2020;44:692-8. [PMID: 32113822 DOI: 10.1016/j.clinre.2020.01.006] [Reference Citation Analysis]
8 Dou W, Yang M, Su Y, Xie R. Dysregulation of miR-3607 predicts prognosis of hepatocellular carcinoma and regulates tumor cell proliferation, migration and invasion. Diagn Pathol 2020;15:54. [PMID: 32404179 DOI: 10.1186/s13000-020-00973-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Huang X, Lai Y, Yao N, Cui Y, Yu X, Cai Z, Tang Y, Huang Y, Zeng J. High expression of microRNA-1266 in hepatocellular carcinoma is associated with poor prognosis of patients and biological cell growth. Oncol Lett 2021;21:347. [PMID: 33747204 DOI: 10.3892/ol.2021.12608] [Reference Citation Analysis]
10 Gu X, Zheng Q, Chu Q, Zhu H. HAND2-AS1: A functional cancer-related long non-coding RNA. Biomed Pharmacother 2021;137:111317. [PMID: 33556872 DOI: 10.1016/j.biopha.2021.111317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Feng Y, Wei G, Zhang L, Zhou H, Wang W, Guo P, Cheng C, Ji L, Cai Q, Feng Y, Tu H. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Bioengineered 2021;12:8217-32. [PMID: 34596006 DOI: 10.1080/21655979.2021.1982272] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]